Robert A. Bradway holds over $221 million in shares of Amgen, a staggering amount that shows his belief in the company’s future. His wealth in Amgen stock has seen significant growth since he became CEO in 2012. This financial commitment...

Robert A. Bradway holds over $221 million in shares of Amgen, a staggering amount that shows his belief in the company’s future. His wealth in Amgen stock has seen significant growth since he became CEO in 2012. This financial commitment goes hand in hand with his management approach, which emphasizes creating lasting value. Notably, at various points during his leadership, he has had notably high stock ownership, signaling confidence in Amgen's trajectory. He has avoided regaining stock options or making significant selling moves, which could suggest a long-term positive outlook for the company's performance ahead. As he focuses on driving innovation and success for Amgen, his holdings not only represent wealth but a passion for the mission at Amgen.